Your browser doesn't support javascript.
loading
Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
Aljedani, Safia S; Liban, Tyler J; Tran, Karen; Phad, Ganesh; Singh, Suruchi; Dubrovskaya, Viktoriya; Pushparaj, Pradeepa; Martinez-Murillo, Paola; Rodarte, Justas; Mileant, Alex; Mangala Prasad, Vidya; Kinzelman, Rachel; O'Dell, Sijy; Mascola, John R; Lee, Kelly K; Karlsson Hedestam, Gunilla B; Wyatt, Richard T; Pancera, Marie.
Afiliação
  • Aljedani SS; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America.
  • Liban TJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America.
  • Tran K; The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, California, United States of America.
  • Phad G; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Singh S; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America.
  • Dubrovskaya V; The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, California, United States of America.
  • Pushparaj P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Martinez-Murillo P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Rodarte J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America.
  • Mileant A; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.
  • Mangala Prasad V; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.
  • Kinzelman R; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.
  • O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Lee KK; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America.
  • Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Wyatt RT; The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, California, United States of America.
  • Pancera M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
PLoS Pathog ; 17(9): e1009543, 2021 09.
Article em En | MEDLINE | ID: mdl-34559844

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Epitopos Imunodominantes / Vacinas contra a AIDS / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Epitopos Imunodominantes / Vacinas contra a AIDS / Produtos do Gene env do Vírus da Imunodeficiência Humana / Anticorpos Neutralizantes Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos